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Systematic analysis of the Hippo 
pathway organization and 
oncogenic alteration in evolution
Yuxuan chen1,2,3, Han Han1,3, Gayoung Seo1, Rebecca Elizabeth Vargas1, Bing Yang1, 
Kimberly chuc1, Huabin Zhao2 & Wenqi Wang1*
the Hippo pathway is a central regulator of organ size and a key tumor suppressor via coordinating 
cell proliferation and death. initially discovered in Drosophila, the Hippo pathway has been implicated 
as an evolutionarily conserved pathway in mammals; however, how this pathway was evolved to 
be functional from its origin is still largely unknown. In this study, we traced the Hippo pathway in 
premetazoan species, characterized the intrinsic functions of its ancestor components, and unveiled the 
evolutionary history of this key signaling pathway from its unicellular origin. In addition, we elucidated 
the paralogous gene history for the mammalian Hippo pathway components and characterized their 
cancer-derived somatic mutations from an evolutionary perspective. Taken together, our findings 
not only traced the conserved function of the Hippo pathway to its unicellular ancestor components, 
but also provided novel evolutionary insights into the Hippo pathway organization and oncogenic 
alteration.
A long-standing question in developmental biology is how metazoan species acquired the ability to precisely con-
trol their tissue/organ size1. This intriguing phenomenon could be traced to some non-metazoan organisms, since 
their aggregative behaviors can be similarly regulated2–4. Initially discovered in Drosophila, the Hippo pathway is 
a highly conserved pathway known for its crucial role in organ size control via restricting cell proliferation and 
inducing apoptosis5–9, shedding light on this fundamental question in evolution.
In Drosophila, the core components of the Hippo pathway comprise two serine/threonine kinases Hippo10–14 
and Warts15,16, adaptor proteins Salvador17,18 and Mats19, a transcriptional co-activator Yorkie20 and a transcrip-
tional factor Scalloped21–23. Together with Salvador, Hippo phosphorylates and activates Warts, which in turn 
phosphorylates Yorkie24,25. Yorkie can shuttle between the cytoplasm and nucleus, a process tightly controlled 
by the Warts-mediated phosphorylation24,25. Upon phosphorylation, Yorkie is recognized by 14-3-3 proteins 
and sequestered in the cytoplasm24,25. When Hippo signaling is inactivated, Yorkie translocates into the nucleus, 
where it forms a complex with Scalloped to initiate the transcription of genes involved in proliferation and 
anti-apoptosis, two critical events required for tissue/organ growth. The Hippo/Salvador-Warts/Mats kinase cas-
cade can be regulated by multiple upstream regulators. Among them, Merlin26, Kibra27–29 and Fat30–32 have been 
implicated to play conserved roles in the mammalian Hippo pathway. Moreover, Hippo is not absolutely required 
for the phosphorylation and activation of Warts, since another two serine/threonine kinases Happyhour and 
Misshapen were also found responsible for Warts activation in both Drosophila and mammals33–35, highlighting 
the complexity of the Hippo pathway regulation.
Although multiple Hippo pathway-related studies have been carried out in species from Drosophila to mam-
mals for decades, its components and functions could have deeper conservative roots in evolution. Indeed, several 
comparative analyses have identified the Hippo pathway components in the ancestor species of cnidarians and 
bilaterians36–39. In addition, a recent study not only further revealed a non-metazoan origin of the Hippo path-
way in evolution, but also uncovered a unicellular organism, Capsaspora owczarzaki, where a complete Hippo 
pathway has already been developed40. Notably, several Hippo pathway core components including Mats, Hippo 
and Warts can be even traced to earlier non-metazoan lineages than Capsaspora owczarzaki40. How theses Hippo 
ancestor components developed their conserved roles in Hippo signaling and how a functional Hippo pathway 
was evolved from these ancestor components are still largely unknown.
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In this study, we traced the evolution of the Hippo pathway organization in both metazoan and non-metazoan 
species. Specifically, we examined the gene duplication history for the Hippo pathway components from 
Drosophila to human and functionally characterized the unicellular ancestors for the Hippo pathway core compo-
nents. Given the crucial role of the Hippo pathway in growth control and cancer inhibition, we also systematically 
analyzed the evolutionarily conserved residues of the Hippo pathway components in human cancer genomes. 
Taken together, our study not only illustrated the roadmap for the Hippo pathway evolution from its unicellular 
origin, but also provided insights into the oncogenic alteration of this key tumor suppressive pathway from a 
novel perspective.
Results
Whole genome duplication results in the emergence of paralogous genes for the mammalian 
Hippo pathway components. Compared to the Drosophila Hippo pathway, an interesting phenomenon 
is the development of paralogous genes for many mammalian Hippo pathway components8,9. For example, the 
Drosophila Hippo pathway components Hippo, Warts and Mats were all duplicated into two paralogous genes 
MST1/MST2, LATS1/LATS2 and MOB1A/MOB1B in mammals, respectively. Some Drosophila Hippo pathway 
components even have more than two paralogous genes in mammals including Scalloped (TEAD1/TEAD2/
TEAD3/TEAD4 in mammals), Kibra (KIBRA or WWC1, WWC2/WWC3 in mammals), Happyhour (MAP4K1/
MAP4K2/MAP4K3/MAP4K5 in mammals) and Misshapen (MAP4K4/MAP4K6/MAP4K7 in mammals). 
However, as for Yorkie (YAP in mammals), Salvador (SAV1 in mammals) and Merlin (NF2 in mammals), they 
remained as one gene in mammals. Moreover, there is no Drosophila orthologous gene for Taz and its evolution-
ary history remains largely unknown.
To elucidate the evolutionary history of the Hippo pathway paralogous genes, we examined the Hippo path-
way components in the species ranging from Drosophila to human. As shown in Fig. 1A, each Hippo pathway 
component only has one orthologous gene within the tested organisms of Insecta, Branchiopoda, Polychaeta, 
Clitellata, Gastropoda, Echinoidea and Leptocardii. Interestingly, the emergence of the Hippo pathway paral-
ogous genes was firstly identified in the fish species and they were remained in amphibians, reptiles and mam-
mals (Fig. 1A). Among the Hippo pathway components, Yorkie and Merlin were actually duplicated in fish too, 
but their paralogs were lost in amphibians and mammals, respectively (Fig. 1A); Taz was originated in fish and 
remained as one gene during evolution (Fig. 1A); no paralogous genes of Salvador were identified in all the tested 
species from Drosophila to human (Fig. 1A). Collectively, these data indicate that fish is the turning point for the 
Hippo pathway in evolution, where many Hippo pathway components acquired their paralogous genes.
Notably, the Hippo pathway paralogous gene number in fish species was highly correlated with the rounds of 
whole genome duplication (WGD) (Fig. S1A), including three rounds of WGD happened in different fish ances-
tors and two in the vertebrate ancestors41. To determine whether WGD resulted in the emergence of the Hippo 
pathway paralogous genes in human, we analyzed the statistical confidence q-score for each paralog pair of the 
Hippo pathway genes in human genome, where several invertebrate species were included as an outgroup. As 
shown in Fig. 1B, the q scores generated among the Hippo pathway paralogous genes were more significant than 
the ones generated between these Hippo pathway genes and control genes, suggesting that these Hippo pathway 
paralogous genes were emerged as a result of WGD. Moreover, compared with the average rate of genes saved 
after WGD in the human genome (30.1%)42, around 72% of the Hippo pathway components retained their dupli-
cated genes after WGD (Fig. 1C). Taken together, these data suggest that the Hippo pathway is highly enriched 
with paralogous genes after the WGD in vertebrate ancestors, allowing its stable role in regulating tissue/organ 
homeostasis within the following species such as amphibians, reptiles and mammals in evolution.
YAp and tAZ share the same evolutionary origin. By analyzing the evolutionary history of the Hippo 
pathway paralogous genes, we noticed that TAZ was firstly identified in fish (Fig. 1A) and it shares a significant 
q-score with YAP in the WGD gene analysis (Fig. 1B). Moreover, YAP and TAZ are similarly regulated and can 
function redundantly in the mammalian Hippo pathway. These evidences suggest that TAZ could be developed 
from Yorkie during WGD. To test this hypothesis, we performed a syntenic analysis of the surrounding regions 
of YAP and TAZ genes in both fish and human genomes, where the ancient vertebrate Ciona intestinalis genome 
was included as an outgroup (Fig. S1B). Interestingly, the genes surrounding Yorkie in Ciona intestinalis genome 
were similar to the genes near YAP and TAZ in both fish and human genomes (Fig. S1B). Moreover, the genomic 
regions near YAP and TAZ showed a strong syntenic correlation between fish and human genomes (Fig. 1D). 
These data are consistent with TAZ and YAP being paralogous genes because of WGD.
In addition to the redundant roles between YAP and TAZ in the Hippo pathway, accumulated evidences also 
indicated that YAP has a stronger influence than TAZ in cellular physiology-related events such as proliferation, 
migration43. To elucidate the functional divergence between YAP and TAZ, we examined their coding sequence 
divergence by using the program DIVERGE 3.044. Interestingly, the YAP and TAZ coding sequences belong to the 
Type I divergence with the coefficient (θ1) significantly greater than 0 (Fig. S1C). This finding suggests a potential 
site-specific rate shift between YAP and TAZ after the gene duplication, which may lead to their partially func-
tional difference.
Roadmap of the Hippo pathway evolution in unicellular species. Next, we further explored how 
a complete Hippo pathway was evolved from its ancestor components. Consistent with a previous study40, most 
of the Hippo pathway core components can be identified in unicellular species (Fig. 2A). Moreover, a functional 
and complete Hippo pathway has already emerged in an unicellular organism Capsaspora owczarzaki40. Actually, 
several Hippo ancestor components can be traced to even earlier unicellular species than Capsaspora owczarzaki 
(Fig. 2A): Mats is the earliest appeared Hippo pathway component that can be identified in the unicellular species 
such as Tetrahymena thermophile, Thalassiosira pseudonana, Chlamydomonas reinhardtii, Trichomonas vaginalis, 
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Naegleria gruberi, Arabidopsis thaliana; following that, Hippo was the next Hippo pathway component appearing 
in Amoebozoa (e.g. Acanthamoeba castellanii), Diclyostelia (e.g. Dictyostelium discoideum) and Apusozoa (e.g. 
Thecamonas trahens); another Hippo pathway kinase cascade component Warts was firstly identified in Fonticula 
alba as well as the following fungi species (e.g. Saccharomyces cerevisiae), while both of these two species did 
not contain Hippo. After these three Hippo components, the kinase cascade (i.e. Hippo/Warts/Mats) and tran-
scriptional complex (i.e. Yorkie/Scalloped) in the Hippo pathway became completed in Spizellomyces punctatus 
and Corallochytrium limacisporum, respectively. Finally, an intact Hippo pathway was eventually developed in 
Capsaspora owczarzaki. (Fig. 2A).
We also examined the co-evolutionary relationship among the Hippo pathway core components by analyzing 
their gene sequences from unicellular organisms to human. Interestingly, the earliest emerged Hippo pathway 
components Mats/MOB1, Warts/LATS and Hippo/MST showed a relatively weak correlation in between and with 
other Hippo pathway components as indicated by the low multiple R value (Fig. 2B). In contrast, strong coevolu-
tion was identified among the Hippo nuclear components (Scalloped/TEAD and Yorkie/YAP), one kinase cascade 
Figure 1. The development of the Hippo pathway paralogous genes is caused by the whole genome duplication 
in fish. (This figure is related to Fig. S1 and Tables S1–S3). (A) Illustration of the Hippo pathway paralogous 
genes in the indicated species from Drosophila to human. The Hippo pathway components were searched in 
the indicated species’ genomes by TBLASTN. The Hippo paralogous gene number in each indicated specie is 
shown. The listed species in Protostomia, Echinodermata and Leptocardii were labeled in grey; the listed species 
in Fish were labeled in pink; the listed species in Terapod were labeled in light blue. (B) The development of the 
Hippo pathway functional paralogous genes was a result of whole genome duplication. The q scores among the 
Hippo pathway functional paralogous genes were more significant than those of control genes. (C) The Hippo 
pathway is enriched with the duplicate genes saved after whole genome duplication as compared with the whole 
human genome. (D) Genomic regions near YAP and TAZ genes in both Danio rerio and Homo sapiens show a 
strong syntenic relationship. The neighboring gene information of YAP and TAZ were obtained from BioMart.
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adaptor (Salvador/SAV1) and two upstream regulators (Merlin/NF2 and Kibra/KIBRA). This result indicated 
that the intrinsic function of Mats/MOB1, Warts/LATS and Hippo/MST could be established independently at 
their evolutionary origins, whose upstream and downstream Hippo pathway components were then coevolved, 
allowing the development of a regulatory network and a functional output for these three Hippo pathway ancestor 
components.
To test this hypothesis, we characterized the roles of the Mats, Hippo and Warts ancestor proteins in 
Tetrahymena thermophile (hereafter called its Mats as “Tetra-Mats” in short), Acanthamoeba castellanii (here-
after called its Hippo as “Acan-Hippo” in short) and Fonticula alba (hereafter called its Warts as “Fonti-Warts” 
in short), respectively, in their corresponding human knockout (KO) cells. Interestingly, both Tetra-Mats and 
Acan-Hippo were able to partially rescue YAP’s cytoplasmic localization in the MOB1A/B double KO (DKO) 
(Fig. 2C) and MST/MAP4K-8KO HEK293A cells (Fig. 2D), respectively. Surprisingly, Fonti-Warts has already 
acquired a full or even a stronger ability to rescue YAP’s cytoplasmic localization in the LATS1/2 DKO HEK293A 
cells as compared to its human othologous protein LATS1 (Fig. 2E). As controls, the MOB1 LATS-unbinding 
mutant (MOB1-E55A) (Fig. 2C), MST1 kinase dead mutant (MST1-KR) (Fig. 2D) and LATS1 kinase dead 
mutant (LATS1-KR) (Fig. 2E) all failed to rescue YAP’s cytoplasmic localization in their corresponding KO cells. 
Figure 2. The Hippo pathway unicellular ancestor components show conserved activities in human cells. (This 
Figure is related to Figs. S2 and S3; Tables S1 and S4). (A) Schematic illustration of the Hippo pathway evolution 
from unicellular organisms to Bilateria. The Hippo pathway components were searched from the genomes of 
the indicated species ranging from Tetrahymena thermophila to Bilateria by TBLASTN. The color of lines was 
matched with the firstly emerged Hippo pathway component in the indicated species. The presumed complex 
formation and regulation were indicated by a question mark. The silhouette figures were made by the authors 
or obtained from http://phylopic.org. (B) Coevolution analysis among the Hippo pathway core components. 
Linear regression analysis was performed to determine the correlation between pairwise evolutionary distances 
based on a multiple protein sequence alignment. (C–E) Three Hippo pathway ancestor components show 
conserved functions in the human cells. The Hippo pathway unicellular ancestor genes Mats (from Tetrahymena 
thermophile), Hippo (from Acanthamoeba castellanii) and Warts (from Fonticula alba) were synthesized and 
respectively expressed in the MOB1A/B double knockout (DKO) (C), MST/MAP4K-8KO (D) and LATS1/2 
DKO (E) HEK293A cells. Immunofluorescence was performed using YAP and Flag antibodies. The human 
MOB1A, MST1 and LATS1 were taken as positive controls, while their inactive mutant MOB1A-E55A, MST1 
kinase-dead mutant (K59R) and LATS1 kinase-dead mutant (K734R) were included as negative controls. Flag-
positive cells (arrows) from ~30 different views (~200 cells in total) were randomly selected and quantified for 
YAP localization. Scale bar, 40 μm.
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Collectively, these results not only suggested the intrinsically conserved Hippo pathway activity for these three 
Hippo ancestor components, but also indicated a different alteration of their activities in evolution.
opposite evolutionary trends exist among the three Hippo pathway ancestor com-
ponents. Next, we further assessed the role of Fonti-Warts by taking human LATS1 as a control in 
MDA-MB-231, a human triple negative breast cancer cell line with the impaired Hippo signaling activity due 
to NF2 deficiency45 (Fig. 3A). Consistent with our reconstitution study (Fig. 2E), Fonti-Warts showed a stronger 
ability than human LATS1 in inducing YAP phosphorylation at S127 (Fig. 3A), promoting YAP’s cytoplasmic 
translocation (Fig. 3B) and inhibiting YAP downstream gene transcription (Fig. 3C). Warts/LATS activation 
requires its association with adaptor Mats/MOB146,47 and the NF2-mediated its membrane translocation and 
the followed Hippo/MST-induced phosphorylation48. Interestingly, Fonti-Warts interacted with human MOB1 
(Fig. 3D) and showed membrane localization even in the NF2-deficient MDA-MB-231 cells (Fig. 3B), suggesting 
that Fonti-Warts has already acquired the basic properties required for its activation. Moreover, Fonti-Warts dis-
played much higher kinase activity than human LATS1 by comparing their abilities to phosphorylate the bacteri-
ally purified GST-YAP (Fig. 3E) and induce their autophosphorylation (Fig. 3F). These data suggested a decrease 
of Warts/LATS kinase activity from its unicellular ancestor in evolution.
Since Mats/MOB1 and Hippo/MST are two key regulators for Warts/LATS, we also characterized their uni-
cellular ancestor proteins Tetra-Mats and Acan-Hippo by taking their human orthologs MOB1 and MST1 as 
controls, respectively. In contrast to human MOB1, we hardly detected the interaction between Tetra-Mats and 
human LATS1 (Fig. 3G), which may explain why Tetra-Mats only partially rescued YAP’ cytoplasmic localiza-
tion in the MOB1A/B DKO cells (Fig. 2C). Moreover, Tetra-Mats failed to bind Fonti-Warts (Fig. 3D). On the 
other hand, the activation of Hippo/MST is regulated by its dimerization and autophosphorylation49–53. Although 
Acan-Hippo can form as a dimer (Fig. 3H), its intrinsic kinase activity is relatively low as compared with human 
MST1 (Fig. 3I,J). Moreover, Acan-Hippo failed to form a complex with human adaptor protein SAV1 (Fig. 3K). 
These functional deficiencies could explain why Acan-Hippo has limited ability to rescue YAP’s cytoplasmic local-
ization in the MST/MAP4K-8KO cells (Fig. 2D). These data indicated that both Mats/MOB1 and Hippo/MST 
may gradually acquire the abilities to regulate Warts/LATS from their unicellular ancestors in evolution.
Collectively, our findings suggested opposite evolutionary directions for the three Hippo pathway ancestor 
components. As for both Tetra-Mats and Acan-Hippo, their intrinsic activities/functions were further acquired 
or strengthened when evolved to their human orthologs (Fig. 3L); while the intrinsic activity of Fonti-Warts was 
diluted in this evolutionary process (Fig. 3L). Given the crucial role of Warts/LATS in relaying the upstream sig-
naling to downstream gene transcription in the Hippo pathway, these opposite evolutionary trends may pioneer 
the fine-tuned regulation of LATS kinase in human.
exploring the oncogenic alteration of the Hippo pathway in evolution. Accumulating evidences 
suggest that dysregulation of the Hippo pathway and hyperactivation of YAP have been frequently associated with 
various types of human cancers including breast, liver, lung, ovary, colon, kidney, brain and others8,9,54. Moreover, 
recent human cancer genome studies also connected the genetic alteration of the Hippo pathway components 
with cancer development55,56. Given the evolutionarily conserved roles for the Hippo pathway components, it will 
be interesting to characterize the oncogenic alteration of the Hippo pathway in evolution.
To achieve this, we profiled the protein sequences of the Hippo pathway core components from unicellular 
species to human, assigned each amino acid residue in these components with a conservation score, and ana-
lyzed the conservative distribution of the Hippo pathway missense mutations derived from two cancer genome 
databases TCGA and COSMIC (Fig. 4A). Actually, these cancer-derived missense mutations were widely distrib-
uted through the whole protein sequences, but not significantly correlated with the conservation of the mutated 
residues (Fig. 4A,B). These results suggested that the Hippo pathway missense mutations could be randomly 
occurred in tumorigenesis (i.e., “passenger” mutations). Interestingly, when all the TCGA missense mutations 
were experimentally characterized using a series of Hippo pathway component KO cells57, a group of missense 
mutations that can functionally inhibit the Hippo signaling activity were found highly enriched in the residues 
with high conservation scores (Fig. 4B). These findings highlighted the significant role of evolutionarily con-
served residues in maintaining a normal tumor suppressive function of the Hippo pathway.
Next, we subjected the Hippo-associated conserved missense mutations to 32 types of human cancers and 
found that they were largely enriched in several types of cancers, such as mesothelioma (MESO) and uterine cor-
pus endometrial carcinoma (UCEC) (Fig. 4C). MESO is known to contain genetic alteration in multiple Hippo 
pathway components such as NF2 and LATS258. Our comparative analysis further suggested MST1, MAP4K4 and 
LATS1 as another group of Hippo pathway components, whose conserved missense mutations may also involve 
in MESO development (Fig. 4C). Unexpectedly, UCEC was found significantly enriched with conserved mis-
sense mutations in multiple Hippo pathway components including KIBRA, MST1, MST2, MAP4K3, MAP4K6, 
MAP4K7, LATS1 and LATS2 (Fig. 4C). Since Hippo signaling dysregulation has not been well characterized in 
UCEC, next, we experimentally tested some of the conserved missense mutations for several frequently-mutated 
Hippo pathway components in UCEC. These missense mutations were chosen from our unpublished Hippo 
pathway somatic mutation screen and were at least reported in different patient samples based on public cancer 
databases (i.e., TCGA, COSMICS). As shown in Fig. 4D,E, these tested missense mutations all failed the Hippo 
pathway components LATS1, LATS2, MST2 and MAP4K3 to rescue YAP’s cytoplasmic localization in their corre-
sponding KO cells, suggesting that alteration of the Hippo pathway components at their evolutionarily conserved 
residues could play an important role in UCEC development.
Taken together, our study not only provided a novel insight into the cancer-related Hippo signaling dysregu-
lation from an evolutionary perspective, but also indicated a new pathological relevance for the Hippo pathway 
in UCEC.
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Discussion
In this study, we focused on the evolutionary history of the Hippo pathway by addressing three questions. First, 
why is the paralogous gene number for the Hippo pathway components different between Drosophila and human? 
Second, although an intact and conserved Hippo pathway can be traced to unicellular species, how was this 
Figure 3. Characterization of the Hippo pathway unicellular ancestor components. (This figure is related 
to Figs. S2–S4). (A–C) Fonticula alba Warts (Fonti-Warts) has a stronger ability than human LATS1 to 
phosphorylate YAP at S127 (A), translocate YAP into the cytoplasm (B) and inhibit YAP downstream gene 
transcription (C) in MDA-MB-231 cells. Flag-positive cells (~200 cells in total) were randomly selected and 
quantified for YAP localization. **p < 0.01, ***p < 0.001 (Student’s t-test). Scale bar, 40 μm. (D) Fonti-Warts 
interacts with human MOB1. HEK293T cells were transfected with the indicated constructs and subjected to 
the pulldown assay. (E and F) Fonti-Warts has a stronger kinase activity than human LATS1. SFB-LATS1, SFB-
LATS1 kinase-dead mutant (LATS1-KR) and SFB-Fonti-Warts were purified from HEK293T cells by using S 
protein beads and washed thoroughly with high-salt buffer containing 250 mM NaCl. In vitro kinase assay was 
performed to examine their abilities to phosphorylate the bacterially purified GST-YAP (E) or induce the auto-
phosphorylation (F). s.e., short exposure. l.e., long exposure. (G) Tetrahymena thermophile Mats (Tetra-Mats) 
failed to bind human LATS1. HEK293T cells were transfected with the indicated constructs and subjected to the 
pulldown assay. (H) Acanthamoeba castellanii Hippo (Acan-Hippo) can form as a dimer. HEK293T cells were 
transfected with the indicated constructs and subjected to the pulldown assay. (I,J) Acan-Hippo has a weaker 
kinase activity than human MST1. SFB-MST1, SFB-MST1 kinase-dead mutant (MST1-KR) and SFB-Acan-
Hippo was purified from HEK293T cells by using S protein beads and washed thoroughly with high-salt buffer 
containing 250 mM NaCl. In vitro kinase assay was performed to examine their abilities to phosphorylate the 
bacterially purified MBP-LATS1 hydrophobic motif (HM) (I) or induce the autophosphorylation (J). s.e., short 
exposure. l.e., long exposure. (K) Acan-Hippo fails to bind human SAV1. HEK293T cells were transfected with 
the indicated constructs and subjected to the pulldown assay. (L) The activities of three Hippo pathway ancestor 
components were evolved differently to their human orthologs. The intrinsic activities of two Hippo pathway 
ancestor components Tetra-Mats and Acan-Hippo are lower than their respective human orthologs MOB1 and 
MST1, suggesting that they improved/acquired their abilities to regulate the Hippo pathway in evolution. The 
intrinsic activity of the Hippo pathway ancestor component Fonti-Warts is higher than its human ortholog 
LATS1, suggesting that its activity was faded to regulate the Hippo pathway in evolution.
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pathway evolved to be a functional one from its ancestor components? Third, what is the connection between the 
Hippo pathway evolution and its oncogenic alteration in cancer development?
As for the current Hippo signaling research, most of our studies are being carried out in the species/model 
systems ranging from Drosophila to mammals. As compared with Drosophila, one of the major differences in 
the mammalian Hippo pathway is the development of paralogous genes for many Hippo pathway components. 
Our current study suggested that the turning point of this paralogous gene number change happened in the 
process of whole genome duplication in fish (Fig. 1A). In addition to the Hippo pathway, our unpublished data 
also showed that the increase of paralogous gene number in other key signaling pathways including PI3K-AKT, 
WNT, NOTCH, TGF-β, was also initiated in fish. Through it, the complexity and stability of these key signaling 
pathways were further developed, which maximized their abilities to control tissue/organism homeostasis. In 
Figure 4. Evolutionary analysis of the Hippo pathway in the human cancer genome. (This figure is related to 
Table S5). (A) A summary of the cancer-derived missense mutations and amino acid conservation information 
for the indicated Hippo pathway components. The cancer-derived missense mutation data were downloaded 
from TCGA (labeled in orange) and COSMIC (labeled in green). The dot size is proportional to the mutation 
number. The conservation scores (1~9; score 1 represents the most variable sites and score 9 represents the most 
conserved sites in evolution) were obtained in Consurf server and labeled in different colors. The key protein 
domains and the start amino acid (arrow) were indicated in the outer ring. (B) The Hippo signaling-associated 
functional missense mutations are enriched in the evolutionarily conserved sites. The distribution of the 
cancer-derived missense mutations was illustrated based on the site conservation scores for the indicated Hippo 
pathway component. The experimentally validated TCGA missense mutations were enriched in the sites with 
high conservation scores. The number of total missense mutations in TCGA and COSMIC and the ratio of the 
experimentally validated TCGA missense mutations were shown. (C) Analysis of the evolutionarily conserved 
missense mutation sites for the Hippo pathway components across 32 TCGA human cancer types. The total case 
number for each indicated cancer type is shown. The missense mutation sites with their conservation scores at 
least 7 were included for the analysis. (D,E) Experimental validation of the UCEC-derived missense mutations 
with high conservation scores in the Hippo pathway component KO cells. The SFB-tagged UCEC-derived 
missense mutants (with conservation scores ≥7, identified in our unpublished Hippo pathway somatic screen, 
reported at least twice in the TCGA and COSMICS) for LATS1, LATS2, MST1, MST2 and MAP4K3 were 
expressed in the indicated LATS1/2 DKO and MST/MAP4K-8KO HEK293A cells and labeled in blue. Kinase 
dead KR mutants were included as negative controls. Representative immunofluorescent staining images were 
shown (D). Flag-positive cells (arrows) from ~10 different views (~100 cells in total) were randomly selected 
and quantified for YAP localization (E). Scale bar, 40 μm.
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addition, we found that TAZ was originated from Yorkie during the whole genome duplication in fish (Figs. 1D 
and S1B), providing an evolutionary insight into their redundant roles in the mammalian Hippo pathway.
To trace the origin of the Hippo pathway, we majorly focused on the firstly emerged Hippo ancestor com-
ponents Mats, Hippo and Warts in the unicellular species Tetrahymena thermophile, Acanthamoeba castellanii 
and Fonticula alba, respectively (Fig. 2A). In contrast to Capsapsora owczarzaki that has already developed an 
intact Hippo pathway40, these unicellular species only have one or two Hippo pathway components (Fig. 2A), 
allowing us to characterize their intrinsic activities at the “true origin” of the Hippo pathway. Interestingly, these 
three Hippo pathway ancestor components all showed conserved functions even in human cells (Fig. 2B) and 
shared key domains and regulatory resides with their orthologs in Capsapsora owczarzaki, Drosophila and human 
(Fig. S2 and S3). These data suggest that the conserved role of the Hippo pathway could be originated from its 
ancestor components.
As compared to their human orthologs, both Mats and Hippo unicellular ancestors were evolved in a “for-
ward” direction where their activities in the Hippo pathway were turned to be strengthened in evolution (Fig. 3L). 
Surprisingly, the evolution of Warts unicellular ancestor seems to be occurred in a “backward” manner (Fig. 3L), 
since its intrinsic kinase activity was much higher than that of its human ortholog LATS (Fig. 3A–F). These find-
ings implicated that regulation of the Warts activity could be a central event driving the Hippo pathway evolution. 
During the course that Warts activity was decreased from its ancestor, the adaptor function of Mats and kinase 
activity of Hippo were both strengthened, a process accompanied by the emergence of additional upstream reg-
ulators and downstream effectors in the Hippo pathway (Fig. 2A). Based on this hypothesis, this activity adjust-
ment process from the three Hippo ancestor components could be gradually compromised in the species where 
most of the Hippo pathway components have been emerged, such as Capsapsora owczarzaki. Indeed, Capsapsora 
owczarzaki Hippo protein has shown a similar level of activity to its Drosophila ortholog in regulating Drosophila 
Yorkie40. Taken together, our findings provide a novel insight into the Hippo pathway evolution from its ancestor 
components to an intact pathway in unicellular organisms.
Cancer can be considered as part of an evolution that is now taking place in human, where its associated 
mutations may result in novel functions and selective advantages59,60. As a well-established tumor suppressor 
pathway in control of tissue homeostasis, the Hippo pathway kindly plays a negative role in this evolutionary pro-
gress. Although the functionally validated missense mutations in the Hippo pathway were highly enriched in the 
conserved sites (Fig. 4B), the ratio is relatively low (Fig. 4B) and the associated cancer type number is also limited 
(Fig. 4C). In contrast, a large portion of the cancer-derived missense mutations were found at the sites with low 
conservation scores (less than 7), but they did not affect the Hippo pathway activity (Fig. 4A,B). These findings 
suggest that mutations at the sites with low conservation may result in novel oncogenic functions for the Hippo 
pathway components to bypass an active Hippo signaling pathway in tumorigenesis.
Here, we systematically analyzed the Hippo pathway in evolution by elucidating its paralogous gene history, 
tracing its conserved functions to its unicellular ancestor components and evaluating its cancer-related dysreg-
ulation from an evolutionary perspective. However, exactly how the Hippo pathway is able to largely reserve its 
conserved functions from its unicellular ancestor species to human is still a mystery. In addition, as a key signal-
ing pathway in maintaining tissue homeostasis and preventing cancer development, it is possible that the Hippo 
pathway could also play a role in regulating an organism’s evolution, which deserves further investigation.
Materials and Methods
Antibodies and chemicals. For Western blotting, anti-α-tubulin (T6199, 1:5000 dilution) and anti-Flag 
(M2) (F3165-5MG, 1:5000 dilution) antibodies were obtained from Sigma-Aldrich. Anti-Myc (sc-40, 1:500 
dilution) and anti-GST antibodies (sc-138, 1:1000 dilution) were purchased from Santa Cruz Biotechnology. 
Anti-phospho-YAP (S127) (4911S, 1:1000 dilution) and anti-phospho-LATS1 (Thr1079) (8654S, 1:1000 dilu-
tion) antibodies were purchased from Cell Signaling Technology. Anti-hemagglutinin (HA) monoclonal antibody 
(901514, 1:2000 dilution) was obtained from BioLegend. Anti-Thiophosphate ester antibody (ab92670, 1:1000 
dilution) was purchased from Abcam. The YAP and MBP polyclonal antibodies were generated as previously 
described57,61. ATP-γ-S kinase substrate (ab138911) and p-Nitrobenzyl mesylate (ab138910) were obtained from 
Abcam. For immunostaining, an anti-YAP (sc-101199, 1:200 dilution) monoclonal antibody was purchased 
from Santa Cruz Biotechnology. Anti-Flag polyclonal antibody (F7425, 1:5000 dilution) was obtained from 
Sigma-Aldrich.
constructs and viruses. Plasmids encoding the indicated genes were obtained from the Human ORFeome 
V5.1 library or purchased from Harvard Plasmid DNA Resource Core. For Tetrahymena thermophila Mats, 
Acanthamoeba castellanii Hippo and Fonticula alba Warts, their sequences were optimized for expression in Homo 
sapiens, synthesized and cloned into a mammalian gene expression vector. All constructs were generated via pol-
ymerase chain reaction (PCR) and subcloned into a pDONOR201 vector using Gateway Technology (Invitrogen) 
as the entry clones. Gateway-compatible destination vectors with the indicated SFB tag, HA tag, Myc tag, GST tag 
or MBP tag were used to express various fusion proteins. PCR-mediated mutagenesis was used to generate all the 
indicated site mutations.
cell culture and transfection. HEK293T cells were purchased from ATCC and kindly provided by Dr. 
Junjie Chen (MD Anderson Cancer Center). HEK293A cells were purchased from ThermoFisher and kindly 
provided by Dr. Jae-Il Park (MD Anderson Cancer Center). MDA-MB-231 cells were purchased from ATCC 
and kindly provided by Dr. Mien-Chie Hung (MD Anderson Cancer Center). HEK293T, HEK293A and 
MDA-MB-231 cells were maintained in Dulbecco’s modified essential medium (DMEM) supplemented with 
10% fetal bovine serum at 37 °C in 5% CO2 (v/v) and 1% penicillin and streptomycin.
Plasmid transfection was performed using polyethylenimine and Lipofectamine 3000 (ThermoFisher).
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Searches of the Hippo pathway genes in different species. The genome data of unicellular eukary-
otes were downloaded from the National Center for Biotechnology Information (https://www.ncbi.nlm.nih.gov/) 
genome database. For each main invertebrate phylum and vertebrate class, two species were chosen as represent-
ative species from unicellular organisms to multicellular organism. Genes encoding the indicated Hippo pathway 
core components were isolated from genome sequences of the selected species. The protein sequences of the 
human and mouse Hippo pathway components were used as queries for the TBLASTN search. The blast results 
were filtered with e-value <10−10. The introns of the predicted sequences were removed by Genewise (https://
www.ebi.ac.uk/Tools/psa/genewise/) by taking their human orthologous genes as queries62. The following unique 
domains that were confirmed by PFAM and SMART databases63,64 were subjected to the gene searches: the TED 
domain was used to identify Scalloped/TEAD; the Mob1 phocein region was used to identify Mats/MOB1; both 
the catalytic domain of the serine/threonine kinase and the MOB1-binding domain were used to identify Warts/
LATS; both the catalytic domain of the serine/threonine kinases and C-terminal SARAH domain were used to 
identify Hippo/MST; both the WW domain and C2 domain were used to identify Kibra/WWC; both the catalytic 
domain of the serine/threonine kinase and CNH domain were used to identify Misshapen or Happyhour/MAP4K; 
the B41 and ERM domains were used to identify Merlin/NF2; two WW domains and coiled-coil domain were 
used to identify Yorkie/YAP; one WW domain and coiled-coil domain were used to identify TAZ (WWTR1); two 
WW domains were used to identify Salvador/SAV1. All the Hippo pathway candidate genes were further verified 
via the phylogenetic reconstruction by taking their human genes as controls. Phylogenetic reconstruction for 
each dataset was conducted as Maximum Likelihood trees using MEGA X with a Tamura-Nei model and 1000 
times bootstrap consensus65.
Sequence alignment and phylogenetic analysis. Sequence alignments were performed by ClustalW 
with default parameters and visualized by BioEdit (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). 
Homologous domains, motifs and important residues were checked by alignment. The nucleotide sequences 
were generated based on the aligned protein sequences and used to reconstruct phylogenetic trees. Specifically, 
the gaps and amino acids with missing information were deleted, allowing all amino acid sequences in a good 
alignment for phylogenetic reconstruction.
The conservation of the Hippo pathway components was estimated by the maximum likelihood paradigm in 
ConSurf server66 using the multiple sequence alignment (MSA) data from all the selected species. The evolution-
ary tree for each dataset was generated based on the species’ evolutionary relationship as estimated by Timetree 
(http://www.timetree.org)67. The conservation score is a relative value and calculated by ConSurf. Based on the 
relative degree of conservation, each amino acid site was assigned with a value from 1 to 9. Score one indicated 
the most variable sites while score 9 represented the most conserved sites. Functional divergence between YAP 
and TAZ was estimated by the program DIVERGE 3.044.
characterization of the genes saved after whole genome duplication. We used the Ohnologs68, 
a database of paralogous genes that were remained from whole genome duplication, to calculate the q score 
between the Hippo pathway genes and their homologous genes, and quantitatively assess the statistical signifi-
cance of each paralogous pair. To identify syntenic clusters among the YAP and TAZ genomic regions in the indi-
cated species, we used BioMart69 to get the information of around 1000 genes surrounding the genes of interest 
and matched them based on the homolog gene information obtained from BioMart. The syntenic clusters were 
visualized using R packages genoPlotR and OmicCircos70,71.
coevolution analysis. Genetic distance from the multiple sequence alignment data was generated by Mega 
X with default parameters65. To examine the co-evolution of the Hippo pathway core components, we used linear 
regression analysis to determine the correlation between pairwise evolutionary distances among the Hippo path-
way components. Pearson’s correlation coefficient (r) was generated as the output of linear regression analysis to 
assess the overall evolutionary correlation between any two-gene pairs of interest.
Immunofluorescent staining. Immunofluorescent staining was performed as described previously72. 
Briefly, cells cultured on coverslips were fixed with 4% paraformaldehyde for 10 minutes at room temperature 
and then extracted with 0.5% Triton X-100 solution for 5 minutes. After blocking with Tris-buffered saline with 
Tween 20 containing 1% bovine serum albumin, the cells were incubated with primary antibodies for 1 hour 
at room temperature. After that, the cells were washed and incubated with fluorescein isothiocyanate- and 
rhodamine-conjugated secondary antibodies for 1 hour. To visualize nuclear DNA, cells were counterstained with 
100 ng/mL 4′,6-diamidino-2-phenylindole (DAPI) for 2 minutes. The coverslips were mounted onto glass slides 
with an anti-fade solution and visualized under a Nikon Ti2-E inverted microscope.
Gene inactivation by CRISPR/Cas9 system. The indicated MOB1A/B and LATS1/2 double knockout 
HEK293A cells were generated through the CRISPR/Cas9 system as described previously57. Briefly, five distinct 
single-guide RNAs (sgRNA) were designed by CHOPCHOP website (https://chopchop.rc.fas.harvard.edu), 
cloned into lentiGuide-Puro vector (Addgene plasmid # 52963), and transfected into HEK293A cells with len-
tiCas9-Blast construct (Addgene plasmid # 52962). The next day, cells were selected with puromycin (2 μg/ml) 
for two days and subcloned to form single colonies. Knockout cell clones were screened by Western blotting to 
verify the loss of targeted protein expression. The MST/MAP4K-8KO HEK293A cells were kindly provided by Dr. 
Kun-Liang Guan (University of California at San Diego).
RNA extraction, reverse transcription and real-time PCR. RNA samples were extracted with TRIzol 
reagent (Invitrogen). Reverse transcription assay was performed using the Script Reverse Transcription Supermix 
Kit (Bio-Rad) according to the manufacturer’s instructions. Real-time PCR was performed using Power SYBR 
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Green PCR master mix (Applied Biosystems). For quantification of gene expression, the 2−ΔΔCt method was used. 
GAPDH expression was used for normalization.
The sequence information for each primer used for gene expression analysis is as follows:
CTGF-Forward: 5′-CCAATGACAACGCCTCCTG-3′;
CTGF-Reverse: 5′-GAGCTTTCTGGCTGCACCA-3′;
CYR61-Forward: 5′-AGCCTCGCATCCTATACAACC-3′;
CYR61-Reverse: 5′-GAGTGCCGCCTTGTGAAAGAA-3′;
GAPDH-Forward: 5′-ATGGGGAAGGTGAAGGTCG-3′;
GAPDH-Reverse: 5′-GGGGTCATTGATGGCAACAATA-3′.
In vitro kinase assay. SFB-LATS1 or its kinase-dead mutant (K734R), SFB-MST1 or its kinase-dead 
mutant (K59R), SFB-Acanthamoeba castellanii Hippo and SFB-Fonticula alba Warts were expressed 
in HEK293T cells for 48 hours. The indicated kinases were then pulled down by S protein beads, 
washed three times in washing buffer (40 mM HEPES, 250 mM NaCl), once in kinase buffer (30 mM 
HEPES, 50 mM potassium acetate, 5 mM MgCl2), and subjected to the kinase assay in the presence 
of cold ATP (500 μM) and 2 μg bacterially-purified GST- YAP or MBP-LATS1-C3 (a region contain-
ing LATS1 hydrophobic motif )57. The reaction mixture was incubated at 30 °C for 30 min, terminated 
with 2x SDS loading buffer and subjected to SDS–PAGE. Phosphorylation of YAP and LATS1-HM were 
determined by YAP S127 and LATS1 T1079 phospho-antibodies, respectively. As for ATP-γ-S-based 
kinase assay, the purified SFB-tagged kinases were subjected to kinase assay in the presence of 500 μM 
ATP-γ-S. The reaction mixture was incubated at 30 °C for 30 min, supplemented with 2.5 mM p-Nitrobenzyl 
mesylate (PNBM) at room temperature for 1 h, terminated with 2x SDS loading buffer and subjected to SDS–
PAGE. The autophosphorylation of the indicated kinases was detected by an anti-Thiophosphate-ester antibody.
Human cancer genome analyses. The missense mutation information of the Hippo pathway genes was 
downloaded from cancer genome databases TCGA (via cBioportal) and COSMIC73,74, and compared with the 
gene conservation data for the Hippo pathway components and our unpublished experimental screen data.
Quantification and statistical analysis. Each experiment was repeated twice or more unless otherwise 
noted. There were no samples excluded for the analyses in this study. Data were analyzed by Student’s t-test. SD 
was used for error estimation. A p value < 0.05 was considered statistically significant.
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